Vaccines for preventing pneumococcal infection in adults (Q24201474)

1

0 references

John Holden

2

0 references

David Paul Tatham

3

0 references

Ross M Andrews

Cochrane Database of Systematic Reviews

4

0 references

publication date

31 January 2013

0 references

published in

0 references

cites work

Clinical efficacy of anti-pneumococcal vaccination in patients with COPD.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Prevention of Pneumococcal Infection by Immunization with Capsular Polysaccharides of Streptococcus pneumoniae: Current Status of Polyvalent Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Effectiveness of pneumococcal polysaccharide vaccine in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Protective Efficacy of Pneumococcal Polysaccharide Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Maxwell Finland Lecture. Random gleanings from a life with the pneumococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan--a representative population-based comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Inefficacy of pneumococcal vaccine in a high-risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Prevention of otitis media in children by pneumococcal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Pneumococcal vaccination and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Response to pneumococcal vaccine in chronic obstructive lung disease—The effect of ongoing, systemic steroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Additive inoculation of influenza vaccine and 23-valent pneumococcal polysaccharide vaccine to prevent lower respiratory tract infections in chronic respiratory disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Serum therapy revisited: animal models of infection and development of passive antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Comparative reactogenicity and immunogenicity of 23 valent pneumococcal vaccine administered by intramuscular or subcutaneous injection in elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Identifying observational studies of surgical interventions in MEDLINE and EMBASE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Efficacy of pneumococcal vaccination in adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Pneumococcal vaccines: confronting the confounders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Mapping of the mouse actin capping protein beta subunit gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Strategies for the control of pneumococcal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Immunoglobulin GM and KM allotypes and vaccine immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

The pneumococcus at the gates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Vaccines for preventing pneumococcal infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Impact of Pneumococcal Vaccination on Morbidity and Mortality of Geriatric Patients: A Case-Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD000422.PUB3

Outbreak of pneumococcal pneumonia among unvaccinated residents of a nursing home--New Jersey, April 2001.

21 January 2018

1 reference

12 December 2020

Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study

1 reference

12 December 2020

Vaccines for preventing influenza in the elderly

1 reference

12 December 2020

Pneumococcal vaccine to counter emerging infectious disease threat in the military

1 reference

12 December 2020

Pneumonia in old age; active immunization against pneumonia with pneumonococcus polysaccharide; results of a six year study

1 reference

12 December 2020

Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older

1 reference

12 December 2020

Clinical effectiveness of pneumococcal vaccine. Meta-analysis

1 reference

12 December 2020

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials

1 reference

12 December 2020

Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine

1 reference

12 December 2020

Benefits of pneumococcal vaccination for bedridden patients

1 reference

12 December 2020

Polyvalent Pneumococcal-Polysaccharide Immunization of Patients with Sickle-Cell Anemia and Patients with Splenectomy

1 reference

12 December 2020

Pneumococcal vaccine efficacy in selected populations in the United States

1 reference

12 December 2020

Three fatal pneumococcal polysaccharide vaccine failures

1 reference

12 December 2020

[Pneumococcal vaccine effectiveness in the elderly. Systematic review and meta-analysis].

1 reference

12 December 2020

Effect of pneumococcal vaccination on upper respiratory tract infections in children. Design of a follow-up study

1 reference

12 December 2020

Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002

1 reference

12 December 2020

Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated

1 reference

12 December 2020

Clinical trial of the protective role of polyvalent pneumococcal vaccine in sickle cell anaemia patients in Zambia

1 reference

12 December 2020

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

1 reference

12 December 2020

Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Pneumococcal vaccine in aboriginal children--a randomized controlled trial involving 60 children

1 reference

12 December 2020

Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska Native chronic alcoholics compared with nonalcoholic Native and non-Native controls

1 reference

12 December 2020

The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease

1 reference

12 December 2020

Vaccines for preventing pneumococcal infection in adults

1 reference

12 December 2020

The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease

1 reference

12 December 2020

Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity

1 reference

12 December 2020

Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study

1 reference

12 December 2020

Prevention of pneumococcal pneumonia by vaccination

1 reference

12 December 2020

Safety of revaccination with pneumococcal polysaccharide vaccine

1 reference

12 December 2020

Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: A matched case–control study

1 reference

12 December 2020

Influence of prior pneumococcal and influenza vaccination on outcomes of older adults with community-acquired pneumonia

1 reference

12 December 2020

Pneumococcal Vaccine in the Institutionalized Elderly: Design of a Nonrandomized Trial and Preliminary Results

1 reference

12 December 2020

No evidence that vaccination with a polysaccharide pneumococcal vaccine protects drug users against all-cause pneumonia

1 reference

12 December 2020

Vaccination against Streptococcus pneumoniae in childhood: lack of demonstrable benefit in young Australian children

1 reference

12 December 2020

Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease

1 reference

12 December 2020

Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up

1 reference

12 December 2020

The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly

1 reference

12 December 2020

Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial

1 reference

12 December 2020

Does pneumococcal vaccine reduce influenza morbidity in humans?

1 reference

12 December 2020

PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA

1 reference

12 December 2020

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

1 reference

12 December 2020

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older

1 reference

12 December 2020

Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions

1 reference

12 December 2020

Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma

1 reference

12 December 2020

Clinical efficacy of pneumococcal vaccination--a prospective study in patients with longstanding emphysema and/or bronchitis

1 reference

12 December 2020

Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults

1 reference

12 December 2020

Protective Effects of the 23‐Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN‐65 Study

1 reference

12 December 2020

10.1002/14651858.CD000422.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23440780

1 reference

Consolidated OpenCitations Corpus – April 2017